Re the successful one year follow up announced in the Journal of American College of Cardiology (thanks Endmorgrimm).
Only one US patient was co-implanted with leadless devices supplied by both Medtronic and EBR. (Granted permission on compassionate grounds). In Europe, similar favourable outcomes have already been demonstrated in “several reports”.
Perhaps it isn’t “breakthrough” news.
Re the successful one year follow up announced in the Journal of...
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
-0.010(1.17%) |
Mkt cap ! $307.6M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.0¢ | 83.5¢ | $694.8K | 820.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 29597 | 84.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 13701 | 3 |
View Market Depth
| Last trade - 15.48pm 04/10/2024 (20 minute delay) ? |
| EBR (ASX) Chart |